http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0166756-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df5016d32b888add7211643738680620 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fddc3a6775379986d5810915b2d059ce |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0036 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-53 |
| filingDate | 2001-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68fd40c4651a1716f295619fbbf02d88 |
| publicationDate | 2001-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-0166756-A2 |
| titleOfInvention | 22105, a human thioredoxin family member and uses thereof |
| abstract | The invention provides isolated nucleic acids molecules, designated 22105 nucleic acid molecules, which encode novel thioredoxin members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 22105 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 22105 gene has been introduced or disrupted. The invention still further provides isolated 22105 proteins, fusion proteins, antigenic peptides and anti-22105 antibodies. Diagnostic methods utilizing compositions of the invention are also provided. |
| priorityDate | 2000-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 799.